Add-on Acquisition • Life Science

Mylan Laboratories Acquires Penederm

On June 24, 1998, Mylan Laboratories acquired life science company Penederm for 205M USD

Acquisition Context

This is Mylan Laboratories’ 1st transaction in the Life Science sector.
This is Mylan Laboratories’ largest (disclosed) transaction.
This is Mylan Laboratories’ 1st transaction in the United States.
This is Mylan Laboratories’ 1st transaction in California.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	June 24, 1998
Target	Penederm
Sector	Life Science
Buyer(s)	Mylan Laboratories
Deal Type	Add-on Acquisition
Deal Value	205M USD

Target Company

Penederm

Foster City, California, United States

Penederm, Inc. develops and markets patented topically administered prescription products. The company currently markets three prescription products to dermatologists in the U.S. through a 41 person direct sales force.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Mylan Laboratories

Secunderabad, India

Category	Company
Sector	Medical Products
Employees	3,000

DESCRIPTION

Mylan Laboratories Limited (Mylan Labs), a subsidiary of U.S.-based Mylan Inc. (Nasdaq: MYL), is one of the world’s largest manufacturers and suppliers of active pharmaceutical ingredients (APIs). Based in Hyderabad, India, Mylan Labs offers more than 150 APIs and intermediates to customers in more than 80 countries across a wide range of therapeutic categories.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 1998	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 1998 M&A